ENTITY

BirchBioMed (BRCB2 US)

2
Analysis
Health Care • United States
BirchBioMed Inc. is a clinical stage biopharmaceutical company focused on developing treatments for scarring (fibrosis), related skin disorders, certain autoimmune diseases, and organ fibrosis. The company holds exclusive, worldwide, non-perpetual pharmaceutical licenses from the University of British Columbia for two scientific technologies, FS1/FS2 and AI-001, which it believes hold potential for significant medical breakthroughs.
more
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
x